Aurobindo Pharma arm restarts production at Kakinada Penicillin-G plant after fire incident

Hyderabad: Aurobindo Pharma has announced the recommencement of the production at Penicillin-G manufacturing facility of Lyfius Pharma Private Limited, a wholly owned step-down subsidiary of the Company, located at Kakinada, Andhra Pradesh.

As per the BSE filing, the restart follows the receipt of the 'Consent to Operate' (CTO) from the Andhra Pradesh Pollution Control Board (APPCB).

This development marks a swift recovery for the company following the fire incident reported in April this year.

As reported by the Medical Dialogues team, a fire broke out around 10:00 PM IST in the vicinity of the coal crusher area, reportedly triggered by the self-ignition of coal. While the incident caused damage to certain ancillary equipment, Aurobindo Pharma confirmed that the core manufacturing infrastructure remained unaffected, and no injuries were reported.

As a precautionary measure and to facilitate necessary equipment replacements, operations were temporarily paused for an estimated period of 20 to 25 days. The company had previously estimated the preliminary loss from the incident to be around Rs 40 million and assured that the facility was fully insured.